IDH1 and glioma: mTOR inhibitor omipalisib, which potently suppresses both mTORC1 and two activities, showed suppression of cell proliferation in both IDH1 wild type and mutated cells (Figure 6A,B), which indicated that mTOR signaling plays essential roles in both glioma molecular subtypes.